Vertex Pharmaceuticals (NASDAQ: VRTX) has made lots of investors quite happy in recent years. The biotech stock has more than doubled over the past three years and trounced the performance for the S&P 500 index in 2018.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,